Creation of modular cell factory for the production of high value chemicals towa...
Creation of modular cell factory for the production of high value chemicals towards Null-pollution
Towards a better future with less pollution, better life quality for humans, animals and plants and more sustainable high-value chemicals under a modular biological system. Microorganisms (Clostridium sp.) will be the driving forc...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BIO2017-88435-R
INGENIERIA METABOLICA EN ASHBYA GOSSYPII PARA EL DESARROLLO...
200K€
Cerrado
RTI2018-094370-B-I00
CONVERSION MICROBIANA DE RESIDUOS LIGNOCELULOSICOS EN PRODUC...
242K€
Cerrado
PID2020-118200RB-I00
INGENIERIA METABOLICA DE BIOPROCESOS EN ASHBYA GOSSYPII PARA...
200K€
Cerrado
PCI2021-121989
ENGINEERING MICROBIAL COMMUNITIES FOR THE CONVERSION OF LIGN...
150K€
Cerrado
BES-2017-080858
BIORREFINERIA DEL GLICEROL: DESARROLLO DE LA FACTORIA CELU...
93K€
Cerrado
PCI2019-111932-2
DESARROLLO, ANALISIS Y CARACTERIZACION FISIOLOGICA DE CONSOR...
150K€
Cerrado
Información proyecto Null-ution
Duración del proyecto: 34 meses
Fecha Inicio: 2022-10-03
Fecha Fin: 2025-08-31
Líder del proyecto
LUNDS UNIVERSITET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
223K€
Descripción del proyecto
Towards a better future with less pollution, better life quality for humans, animals and plants and more sustainable high-value chemicals under a modular biological system. Microorganisms (Clostridium sp.) will be the driving force, and carbon dioxide (CO2) will be the fuel required to grow and produce the high-value chemicals. The modularity will allow the same organism to act as a multi-product factory, based on the benefit and requirements. We aim to select the Clostridium sp. based on their ability to capture CO2. Enzymes involved in CO2 metabolism will be subjected to improvement; either the same enzymes will be mutated or substituted by a better biocatalyst from the natural inventory. Once satisfactory CO2 utilization/organism growth levels are achieved, designed constructs targeting specific pathways will be transformed into the recombinant organism to validate their modularity. We have selected bioplastic and butanol as the target model products. Consequently, new genes will be assembled into a single plasmid and subsequently transformed into the microorganism. The product levels and efficiency of the new system will be evaluated.